Anti-angiogenic drug scheduling optimisation with application to colorectal cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-angiogenic drug scheduling optimisation with application to colorectal cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-07-19
DOI
10.1038/s41598-018-29318-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Colorectal tumour simulation using agent based modelling and high performance computing
- (2017) Guiyeom Kang et al. Future Generation Computer Systems-The International Journal of eScience
- Model driven optimization of antiangiogenics + cytotoxics combination: application to breast cancer mice treated with bevacizumab + paclitaxel doublet leads to reduced tumor growth and fewer metastasis
- (2017) Severine Mollard et al. Oncotarget
- Numerical simulation of vascular tumour growth under antiangiogenic treatment: addressing the paradigm of single-agent bevacizumab therapy with the use of experimental data
- (2016) Katerina D. Argyri et al. Biology Direct
- A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme)
- (2016) Antonio Avallone et al. BMC CANCER
- Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy
- (2016) Etienne Becht et al. CLINICAL CANCER RESEARCH
- Modelling tumour cell proliferation from vascular structure using tissue decomposition into avascular elements
- (2016) Maximilian O. Besenhard et al. JOURNAL OF THEORETICAL BIOLOGY
- Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
- (2014) Naveen S. Vasudev et al. ANGIOGENESIS
- Transient Antiangiogenic Treatment Improves Delivery of Cytotoxic Compounds and Therapeutic Outcome in Lung Cancer
- (2014) S. Chatterjee et al. CANCER RESEARCH
- Mathematical Modeling of Tumor Growth and Treatment
- (2014) Heiko Enderling et al. CURRENT PHARMACEUTICAL DESIGN
- Semi-physiological pharmacokinetic–pharmacodynamic (PK–PD) modeling and simulation of 5-fluorouracil for thrombocytopenia in rats
- (2014) Shinji Kobuchi et al. XENOBIOTICA
- Bevacizumab-Induced Normalization of Blood Vessels in Tumors Hampers Antibody Uptake
- (2013) M. Arjaans et al. CANCER RESEARCH
- Benefits of Vascular Normalization Are Dose and Time Dependent--Letter
- (2013) Y. Huang et al. CANCER RESEARCH
- Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy
- (2013) N. R. Smith et al. CLINICAL CANCER RESEARCH
- Bevacizumab reduces tumor targeting of antiepidermal growth factor and anti-insulin-like growth factor 1 receptor antibodies
- (2013) Sandra Heskamp et al. INTERNATIONAL JOURNAL OF CANCER
- Combining two strategies to improve perfusion and drug delivery in solid tumors
- (2013) T. Stylianopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Towards Predicting the Response of a Solid Tumour to Chemotherapy and Radiotherapy Treatments: Clinical Insights from a Computational Model
- (2013) Gibin G. Powathil et al. PLoS Computational Biology
- Pharmacokinetics, Lymph Node Uptake, and Mechanistic PK Model of Near-Infrared Dye-Labeled Bevacizumab After IV and SC Administration in Mice
- (2012) Fang Wu et al. AAPS Journal
- Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs
- (2012) Astrid A.M. Van der Veldt et al. CANCER CELL
- Modelling the effects of cell-cycle heterogeneity on the response of a solid tumour to chemotherapy: Biological insights from a hybrid multiscale cellular automaton model
- (2012) Gibin G. Powathil et al. JOURNAL OF THEORETICAL BIOLOGY
- A survey of optimization models on cancer chemotherapy treatment planning
- (2011) Jinghua Shi et al. ANNALS OF OPERATIONS RESEARCH
- Computational Modeling of Tumor Response to Vascular-Targeting Therapies—Part I: Validation
- (2011) Jana L. Gevertz Computational and Mathematical Methods in Medicine
- Practical limits for reverse engineering of dynamical systems: a statistical analysis of sensitivity and parameter inferability in systems biology models
- (2011) Kamil Erguler et al. Molecular BioSystems
- Tumor Angiogenesis and Vascular Patterning: A Mathematical Model
- (2011) Rui D. M. Travasso et al. PLoS One
- Rapid Chemotherapy-Induced Acute Endothelial Progenitor Cell Mobilization: Implications for Antiangiogenic Drugs as Chemosensitizing Agents
- (2008) Yuval Shaked et al. CANCER CELL
- Clinical pharmacokinetics of bevacizumab in patients with solid tumors
- (2008) Jian-Feng Lu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
- Approximate Bayesian computation scheme for parameter inference and model selection in dynamical systems
- (2008) T. Toni et al. Journal of the Royal Society Interface
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started